Insider Shareholders with Direct Ownership of Apellis Pharmaceuticals, Inc. (APLS)
This section provides a comprehensive overview of the insiders with direct ownership of Apellis Pharmaceuticals, Inc. (APLS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Apellis Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Morningside Venture Investments Ltd
> 10% Shareholder |
250,000 | 0 | 12,806,342 $260 Million | 1 |
Nov 18, 2021
Added 1.91%
|
|
Cormorant Asset Management, Lp
> 10% Shareholder |
3,473,925 | 0 | 3,473,925 $70.6 Million | 1 |
Nov 13, 2017
Added 23.57%
|
|
Pascal Deschatelets
Chief Scientific Officer |
791,634 | 487,538 | 1,160,496 $23.6 Million | 80 |
May 21, 2025
Added 1.09%
|
|
Alec Machiels
Director |
198,195 | 72,750 | 384,989 $7.83 Million | 83 |
Jan 01, 2026
Added 2.03%
|
|
Cedric Francois
Chief Executive Officer |
1,602,151 | 1,978,625 | 331,605 $6.74 Million | 57 |
Jul 17, 2025
Reduced 5.61%
|
|
A. Sinclair Dunlop
Director |
178,248 | 16,681 | 161,567 $3.28 Million | 25 |
Jan 01, 2026
Added 4.7%
|
|
Timothy Eugene Sullivan
Chief Financial Officer |
327,577 | 240,510 | 110,936 $2.26 Million | 41 |
Oct 21, 2025
Reduced 8.27%
|
|
David O. Watson
General Counsel |
273,728 | 212,514 | 104,618 $2.13 Million | 54 |
Jan 07, 2026
Added 0.84%
|
|
Kelley Boucher
Chief People Officer |
97,658 | 0 | 97,658 $1.99 Million | 3 |
Sep 02, 2025
Added 23.78%
|
|
Federico Grossi
Chief Medical Officer |
111,687 | 46,968 | 94,884 $1.93 Million | 56 |
Jan 05, 2023
Reduced 2.57%
|
|
Caroline Baumal
Chief Medical Officer |
100,588 | 10,440 | 91,206 $1.85 Million | 7 |
Jan 05, 2026
Reduced 3.21%
|
|
Adam J. Townsend
Chief Commercial Officer |
289,048 | 237,650 | 84,050 $1.71 Million | 49 |
Jan 29, 2025
Reduced 0.82%
|
|
Mark Jeffrey De Long
Chief Business & Strat Officer |
151,961 | 82,509 | 83,945 $1.71 Million | 50 |
Feb 11, 2025
Reduced 0.43%
|
|
Nur Nicholson
Chief Technical Officer |
133,545 | 52,340 | 83,664 $1.7 Million | 21 |
Jan 29, 2025
Reduced 0.98%
|
|
Karen Lewis
Chief People Officer |
105,449 | 36,094 | 70,251 $1.43 Million | 28 |
Jan 29, 2025
Reduced 0.52%
|
|
Lukas Scheibler
Chief Research Officer |
124,724 | 71,506 | 68,299 $1.39 Million | 30 |
Dec 01, 2023
Reduced 12.77%
|
|
Leslie Meltzer
Chief Research and Development |
61,804 | 0 | 61,804 $1.26 Million | 1 |
Aug 26, 2025
Added 50.0%
|
|
Jeffrey Eisele
Chief Development Officer |
85,486 | 30,174 | 55,312 $1.12 Million | 29 |
Jan 29, 2025
Reduced 0.5%
|
|
James George Chopas
VP/Chief Accounting Officer |
58,774 | 8,989 | 53,468 $1.09 Million | 26 |
Sep 15, 2025
Reduced 0.35%
|
|
Paul R. Fonteyne
Director |
25,666 | 0 | 30,666 $623,439 | 5 |
Jan 01, 2026
Added 20.61%
|
|
Gerald Chan
Director |
25,666 | 0 | 25,666 $521,789 | 5 |
Jan 01, 2026
Added 23.67%
|
|
Stephanie Monaghan O'Brien
Director |
25,666 | 0 | 25,666 $521,789 | 5 |
Jan 01, 2026
Added 23.67%
|
|
Craig A Wheeler
Director |
24,444 | 0 | 24,444 $496,946 | 2 |
Jan 01, 2026
Added 24.57%
|
|
Victoria L. Brown
Program Team Lead |
36,598 | 17,157 | 23,556 $478,893 | 14 |
Jan 20, 2023
Reduced 5.66%
|
|
Keli Walbert
Director |
17,051 | 0 | 17,051 $346,646 | 2 |
Jan 01, 2026
Added 31.83%
|
|
Nicole D Perry
Vice President - Accounting |
32,500 | 30,153 | 4,847 $98,539 | 22 |
Aug 02, 2021
Reduced 17.1%
|